GENinCode (LON:GENI) Releases Quarterly Earnings Results

GENinCode (LON:GENI) issued its earnings results on Tuesday. The company reported GBX (0.38) earnings per share (EPS) for the quarter, Digital Look Earnings reports. GENinCode had a negative return on equity of 409.40% and a negative net margin of 185.47%.

GENinCode Price Performance

Shares of GENI traded down GBX 0.17 during trading hours on Tuesday, hitting GBX 0.70. The stock had a trading volume of 22,954,143 shares, compared to its average volume of 5,146,545. The stock has a market capitalization of £5.27 million, a price-to-earnings ratio of -0.34 and a beta of 0.59. The company has a debt-to-equity ratio of 117.74, a current ratio of 0.93 and a quick ratio of 15.88. The company’s fifty day moving average is GBX 0.88 and its two-hundred day moving average is GBX 0.99. GENinCode has a 52 week low of GBX 0.64 and a 52 week high of GBX 4.90.

GENinCode Company Profile

GENinCode Plc is a UK based company specialising in genetic risk assessment of cardiovascular disease. Cardiovascular disease is the leading cause of death and disability worldwide.

GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U.

GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies. GENinCode CE marked invitro-diagnostic molecular tests combine clinical algorithms and bioinformatics to provide advanced patient risk assessment to predict disease onset.